Back
Beam Therapeutics Stock Price Chart
Sponsored
BEAM
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
32
BEAM
Beam Therapeutics
Last Price:
25.66
Seasonality Move:
30.53%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight buying pressure.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.41 | Buy |
20-day SMA: | 25.31 | Buy |
50-day SMA: | 26.3 | Sell |
200-day SMA: | 27.31 | Sell |
8-day EMA: | 25.44 | Buy |
20-day EMA: | 25.3 | Buy |
50-day EMA: | 25.54 | Buy |
200-day EMA: | 26.92 | Sell |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 51.87 | Buy |
Chaikin Money Flow: | 83316 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.08 - 26.32) | Buy |
Bollinger Bands (100): | (22.77 - 27.33) | Buy |
Beam Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 25.67 while BEAM 8-day simple moving average is 25.41, which is a Buy signal.
- The stock price of BEAM is 25.67 while Beam Therapeutics 20-day SMA is 25.31, which makes it a Buy.
- Beam Therapeutics 50-day simple moving average is 26.30 while BEAM share price is 25.67, making it a Sell technically.
- BEAM stock price is 25.67 and Beam Therapeutics 200-day simple moving average is 27.31, creating a Sell signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a Sell
The current Beam Therapeutics [BEAM] share price is $25.67. The Score for BEAM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics Stock Info
Market Cap:
2.12B
Price in USD:
25.67
Share Volume:
999.79K
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
16.95
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?
The Beam Therapeutics stock price is 25.67 USD today. -
Will BEAM stock go up or go down?
Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Beam Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is overvalued.
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 25.67 while BEAM 8-day exponential moving average is 25.44, which is a Buy signal.
- The stock price of BEAM is 25.67 while Beam Therapeutics 20-day EMA is 25.30, which makes it a Buy.
- Beam Therapeutics 50-day exponential moving average is 25.54 while BEAM share price is 25.67, making it a Buy technically.
- BEAM stock price is 25.67 and Beam Therapeutics 200-day simple moving average is 26.92, creating a Sell signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.48 per share, and an increase next year of $0.06 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
- BEAM Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Beam Therapeutics is a Sell
- Beam Therapeutics Relative Strength Index (RSI) is 51.87, which suggest Beam Therapeutics is overbought
- The Bollinger Bands (25) for Beam Therapeutics is (24.08 - 26.32), which suggest Beam Therapeutics is a Buy
- The Bollinger Bands (100) for Beam Therapeutics is (22.77 - 27.33), which suggest Beam Therapeutics is a Buy
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.